|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for SANOFI-AVENTIS SA (NYSE:SNY) Stock.
SNY stock opening price was $38.06 per share.
Current price of NYSE:SNY Stock is $38.22 per share
and it is
$+0.26, (+0.68%) today
and it was trading in the daily range of $37.66 - 38.30 per share.
Current Bid Price for (NYSE:SNY) stock is $37.25 and the Ask Price is $39.06. In the last 52 weeks
SNY stock was trading in the range of $23.95 - 40.17. 50-Day Moving Average for (NYSE:SNY) stock is
$37.8197 and 200-Day Moving Average is $33.5634. On average analysts predict that One Year Target Estimated price for
(NYSE:SNY) stock is $43.50.
SANOFI-AVENTIS SA (NYSE:SNY) Market capitalization is $99.797B. (NYSE:SNY) stock average daily volume is
1,458,550 shares per day.
However, on last trading session of Nov 13, 2009
SNY stock traded 1,385,729 shares.
Also The Short Ratio for (NYSE:SNY) stock is 1.70.
On previous trading session SNY Stock closed at $37.96 per share.
Last year SANOFI-AVENTIS SA (NYSE:SNY) before taxes (EBITDA) (ttm) earned $0 on total revenue of $0.
Earnings Per Share - EPS (ttm) for SNY stock is 0.00.
Thus, (NYSE:SNY) Stock Price/Sales (ttm) ratio is N/A and Price/Book (mrq) ratio is N/A.
(NYSE:SNY) Stock pays a dividend of $1.419 per share which is a yield of 3.74%.
So at this time (NYSE:SNY) Stock maintains Trailing Annual Dividend Rate at 1.419
.
StockRing Recommendations for SANOFI-AVENTIS SA (NYSE:SNY) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=SNY
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
SNY Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
 | |
| 1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
| 1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
| |
| 5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
| 5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
SNY Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
| Last Trade: |
38.22 |
| Trade Time: |
Nov 13 |
| Change: |
+0.26, (+0.68%) |
| Prev Close: |
37.96 |
| Open: |
38.06 |
| Bid: |
37.25 |
| Ask: |
39.06 |
| 1y Target Est: |
$43.50 |
| 50-Day Moving Average: |
37.8197 |
200-Day Moving Average:
|
33.5634 |
| Short Ratio: |
1.70 |
| Trailing Annual Dividend Rate: |
1.419
|
|
| Day's Range: |
37.66 - 38.30 |
| 52wk Range: |
23.95 - 40.17 |
| Volume: |
1,385,729 |
| Avg Vol: |
1,458,550 |
| Market Cap: |
99.797B |
| P/E (ttm): |
N/A |
| EPS (ttm): |
0.00 |
| Div & Yield: |
1.419 (3.74%) |
| Revenue (ttm): |
0 |
| Earnings before Tax (EBITDA) (ttm): |
0 |
| Price/Sales (ttm): |
N/A |
| Price/Book (mrq): |
N/A |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS | |
| |
|
SANOFI-AVENTIS SA (NYSE: SNY) Company Information
Sanofi-Aventis
174 Avenue De France
Cedex 13
Paris, 75635
France - Map
Phone: 33 1 53 77 40 00
Fax: 33 1 53 77 41 33
Web Site: http://www.sanofi-aventis.com
SANOFI-AVENTIS SA (NYSE: SNY) DETAILS
SANOFI-AVENTIS SA (NYSE: SNY) Index Membership: N/A
SANOFI-AVENTIS SA (NYSE: SNY) Sector: Healthcare
SANOFI-AVENTIS SA (NYSE: SNY) Industry: Drug Manufacturers - Major
SANOFI-AVENTIS SA (NYSE: SNY) Full Time Employees: 98,213
SANOFI-AVENTIS SA (NYSE: SNY) BUSINESS SUMMARY
Sanofi-Aventis, a pharmaceutical company, contributes to enhancing life by providing an offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company has products in the areas of thrombosis, cardiovascular, metabolic diseases, oncology, central nervous system, internal medicine, and vaccines. Its primary medicines include Lovenox/Clexane, Plavix/Iscover, Aprovel/Avapro/Karvea, Tritace/Triatec/Delix/Altace, Lantus, Amaryl/Amarel/Solosa, Acomplia, Taxotere, Eloxatine, Stilnox/Ambien/Myslee, Copaxone, Depakine, Allegra/Telfast, Nasacort, Xatral/Uroxatral, and Actonel/Optinate/Acrel. The company?s vaccines principally include pediatric combination and poliomyelitis vaccines, influenza vaccines, meningitis/pneumonia vaccines, adult and adolescent booster vaccines, and travel and endemic vaccines. It has collaboration agreements principally with Novozymes, Dyax Corp., Oxford BioMedica, Regeneron, IDM, Zealand Pharma, UCB, and Crucell N.V., as well as partners, including Immunogen, Coley, Wayne State University, Innogenetics, Inserm, and Micromet Inc. The company also has an agreement with Drugs For Neglected Diseases Initiative (dndi) for the development, manufacturing, and distribution of fexinidazole, a drug for the treatment of human African trypanosomiasis; and a licensing agreement with Wellstat Therapeutics Corporation to develop, manufacture, and commercialize PN2034, an oral insulin sensitizer for the treatment of Type II diabetes. In addition, the company has interest in Merial Limited, an animal health company that provides a range of products to enhance the health, well-being, and performance of animals. Sanofi-Aventis was founded in 1970 and is headquartered in Paris, France.
SANOFI-AVENTIS SA (NYSE: SNY) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Chris Viehbacher , Age: 48
Chief Exec. Officer, Managing Director, Director and Member of Strategy Committee Salary: N/A Bonus: N/A
Mr. Nigel Brooksby , Age:
Chairman of Sanofi-Aventis UK, Managing Director of Sanofi-Aventis UK and Gen. Mang. of Group UK Salary: N/A Bonus: N/A
Mr. Jerome Contamine , Age: 51
Chief Financial Officer and Exec. VP Salary: N/A Bonus: N/A
Mr. Gilles Lhernould , Age: 53
Sr. VP Corp. Social Responsibility and Member of the Management Committee Salary: N/A Bonus: N/A
Mr. Hanspeter Spek , Age: 59
Pres of Global Operations Salary: N/A Bonus: N/A
|
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
|
Stock Market UpdateBriefing.comIn France, the CAC is up 0.2% with help from Sanofi-Aventis (SNY) and Renault, which issued a strong profit forecast. That has helped offset weakness among ...and more » |
|
US HOT STOCKS: Toll Brothers, ING, Las Vegas Sands, Macy'sWall Street JournalRegeneron Pharmaceuticals Inc. (REGN, $18.74, +$2.94, +18.61%) and Sanofi-Aventis SA (SNY, $37.95, +$0.06, +0.15%) said they are expanding their drug ...US HOT STOCKS: Toll Brothers, ING, Las Vegas Sands, Macy'sWall Street Journalall 4 news articles » |
|
Stock Market UpdateBriefing.comSanofi-Aventis (SNY) is currently weighing on trade, though. In Asia, the MSCI Asia Pacific Index closed 0.4% lower, while Japan's Nikkei fell 1.3%. ...and more » |
|
Stock Market UpdateBriefing.comSanofi-Aventis (SNY) is a primary laggard, but GDF Suez is showing positive leadership. Markets in Asia performed well during Tuesday's trade. ...and more » |
|
|
No comments:
Post a Comment